Contents

Abstract 37

4.1 Cardiovascular Physiology, Pharmacology and Therapeutics 38

4.2 Drugs in Development and Novel Drug Targets 42

4.3 Receptor Subtypes as Novel Targets 45

4.4 Receptor Gene Polymorphisms 47

4.5 Concluding Remarks 48

References 49

0 0

Post a comment